Skip to main content

7 Result(s)

within R Aloyz Remove this filter

and

  1. Article

    Open Access

    Pharmacological targeting of eIF4E in primary CLL lymphocytes

    V Martinez-Marignac, M Shawi, E Pinedo-Carpio, X Wang, L Panasci… in Blood Cancer Journal (2013)

    Download PDF (578 KB) View Article

  2. No Access

    Chapter

    DNA-PK in CLL Chemotherapy

    DNA is the principal target of many conventional anticancer agents, and inhibition of DNA repair is one of the most promising strategies in novel cancer therapy. Many studies demonstrated that nonhomologous en...

    L. Amrein, D. Davidson, R. Aloyz, L. Panasci in Advances in DNA Repair in Cancer Therapy (2013)

  3. Article

    Open Access

    Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score

    Immunohistological assessment of Ki 67 expression is less expensive than Oncotype Dx, which is currently used to identify patients with lymph node-negative breast cancer, who will benefit from adjuvant chemoth...

    S Sahebjam, R Aloyz, D Pilavdzic, M-L Brisson, C Ferrario… in British Journal of Cancer (2011)

    Download PDF (182 KB) View Article

  4. No Access

    Article

    ZRF4, a combi-molecule with increased efficacy as compared with the individual components in chronic lymphocytic leukemia lymphocytes in vitro

    L Amrein, Z Rachid, B Jean-Claude, D Soulières, R Aloyz, L Panasci in Leukemia (2011)

  5. No Access

    Article

    Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia

    Treatments for hematological malignancies have improved considerably over the past decade, but the growing therapeutic arsenal has not benefited adult T-cell leukemia (ATL) patients. Oncolytic viruses such as ...

    R Césaire, S Olière, E Sharif-Askari, M Loignon, A Lézin, S Olindo, G Panelatti… in Oncogene (2006)

  6. No Access

    Article

    Reply to ‘Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4’ by Chow et al

    R Aloyz, L Panasci in Leukemia (2005)

  7. No Access

    Article

    Imatinib sensitizes CLL lymphocytes to chlorambucil

    The effect of imatinib on chlorambucil (CLB) cytotoxicity in chronic lymphocytic leukemia (CLL) lymphocytes was examined in vitro. Imatinib sensitizes the WSU and I83 human CLL cell lines, 10- and two-fold, respe...

    R Aloyz, K Grzywacz, Z-Y Xu, M Loignon, M A Alaoui-Jamali, L Panasci in Leukemia (2004)